Return to homepagePandemic Pact

THRIXEN - RAPID AND MULTIPLEX POINT-OF-CARE TEST FOR EBOLA AND MALARIA DIAGNOSTICS (THRIXEN)

  • Funded by Biomedical Advanced Research and Development Authority (BARDA)
  • Total publications:0 publications

Grant number: 75A50124C00045

Grant search

Key facts

  • Disease

    Ebola

  • Start & end year

    2024
    2026

  • Known Financial Commitments (USD)

    $733,720

  • Funder

    Biomedical Advanced Research and Development Authority (BARDA)

  • Research Location

    Singapore

  • Lead Research Institution

    THRIXEN PTE. LTD.

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

THRIXEN - RAPID AND MULTIPLEX POINT-OF-CARE TEST FOR EBOLA AND MALARIA DIAGNOSTICS (THRIXEN)